Unresectable or Metastatic Solid Tumors

Also known as: Metastatic or Unresectable Solid Tumors

Drug	Drug Name	Drug Description
DB08911	Trametinib	A kinase inhibitor used alone or in combination with dabrafenib to treat patients with cancers with specific BRAF mutations, such as melanoma and non-small cell lung cancer.

Drug	Drug Name	Target	Type
DB08911	Trametinib	Cytochrome P450 2C8	enzyme
DB08911	Trametinib	Cytochrome P450 3A4	enzyme
DB08911	Trametinib	Dual specificity mitogen-activated protein kinase kinase 1	target
DB08911	Trametinib	Dual specificity mitogen-activated protein kinase kinase 2	target

Drug	Drug Name	Phase	Status	Count
DB11717	Epacadostat	1	Completed	1
DB14867	Parsaclisib	1	Completed	1
DB15766	Retifanlimab	1	Completed	1